STAT3 and prostate carcinoma: NDV can induce CRT membrane translocation, the release of HMGB1, HSP70/90, and ATP in melanoma and prostate cancer cells, which could be enhanced by the STAT3 inhibitor or shRNA‐mediated depletion of STAT3 [20, 21].